Tenacissoside I
CAS: 191729-44-9
Rif. 3D-FT74349
| 2mg | Prezzo su richiesta | ||
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
- (3β,5α,11α,12β,14β,17α)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl benzoate
- Pregnan-20-one, 12-(acetyloxy)-11-(benzoyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy]-8,14-epoxy-, (3β,5α,11α,12β,14be ta,17α)-
- (3beta,5alpha,11alpha,12beta,14beta,17alpha)-12-(Acetyloxy)-11-(benzoyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-beta-D-allopyranosyl)-3-O-methyl-beta-D-arabino-hexopyranosyl]oxy]-8,14-epoxypregnan-20-one
- Tenacissimoside B
Tenacissoside I is a polyhydroxylated triterpene compound derived from the Chinese herb, Tenacissus. It has been shown to have an anticancer activity by binding to epidermal growth factor receptor and blocking the downstream signaling pathway. Tenacissoside I has also been found to inhibit glucose uptake in human liver cells. This drug is then metabolized into tenacissoside II and tenacissoside III, which are also active compounds. Tenacissoside I inhibits protein synthesis by competing with insulin for its receptor on the surface of cells, which results in a decreased glucose uptake.
Proprietà chimiche
Richiesta tecnica su: 3D-FT74349 Tenacissoside I
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
